Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10 MG prednisone
(D00473)
----[1] 44 💬
215-DAY taper prednisone
(D00473)
----[1] 46 💬
3150-DAY taper prednisone
(D00473)
----[1] 46 💬
45 MG prednisone
(D00473)
----[1] 44 💬
55-aminosalicylic acid(5-ASA) and/or prednisone
(D00473)
[1] Mesalazine[1] Mesalamine 💬 --[1] 97 💬
6Adalimumab, plus prednisone
(D00473)
[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
7Administration OF methylprednisolone + prednisone + mycophenolate mofetil
(D00473)
----[1] 49 💬
8Azathioprine/prednisone
(D00473)
[1] Azathioprine[2] Azathioprine ,
Azathioprine sodium 💬
--[1] 85 💬
9Capsule DI prednisone
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
10Chinese herb prescription granule plus prednisone
(D00473)
----[1] 66 💬
11Cyclophosphamide, azathioprine,prednisone,methylprednisolone
(D00473)
[2] Cyclophosphamide,
Prednisone
[3] Cyclophosphamide ,
Prednisone (D00473),
Cyclophosphamide 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45 💬
12Cyclophosphamide-prednisone-azathioprine
(D00473)
[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬
--[1] 49 💬
13Data collection FOR prednisone metabolism
(D00473)
----[1] 41 💬
14Duchenne muscular dystrophy group with prednisone/predisolone
(D00473)
----[1] 113 💬
15Granulocyte-colony stimulating factor (G-CSF) and prednisone
(D00473)
----[1] 13 💬
16Hydroxychloroquine + LOW-dose prednisone
(D00473)
[2] Hydroxychloroquine,
Prednisone
[3] Prednisone (D00473),
Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
17Hydroxychloroquine + prednisone
(D00473)
[2] Hydroxychloroquine,
Prednisone
[3] Prednisone (D00473),
Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
18IR prednisone
(D00473)
----[1] 46 💬
19Leflunomide 20 MG+prednisone 0.5MG/KG/D
(D00473)
[1] Leflunomide[1] Leflunomide 💬 [1] DHODH 💬 [1] Pyrimidine metabolism 💬[1] 66 💬
20Methylprednisone/prednisone
(D00473)
[1] Methylprednisone---[1] 85 💬
21MR prednisone
(D00473)
----[1] 46 💬
22Mycophenolate mofetil plus lower dose OF prednisone
(D00473)
[3] Mycophenolate mofetil,
Mycophenolic acid,
Prednisone
[5] Prednisone (D00473),
Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬
[3] IMPDH,
IMPDH,
NR3C1 💬
[3] Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 66 💬
23Oral prednisone 5MG
(D00473)
----[1] 49 💬
24Over encapsulated prednisone
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
25Prednisolone/prednisone
(D00473)
[1] Prednisolone[1] Prednisolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
26Prednisone
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[54] 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
27Prednisone - azathioprine
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 11 💬
28Prednisone 0,5 MG/KG orally ON alternate days
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
29Prednisone 1 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
30Prednisone 15 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
31Prednisone 2 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
32Prednisone 3 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
33Prednisone 4 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
34Prednisone 5 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 46, 66 💬
35Prednisone 5 MG tablets
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
36Prednisone 7.5 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
37Prednisone acetate
(D00473)
[2] Prednisone,
Prednisone acetate
[2] Prednisone (D00473),
Prednisone acetate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[6] 35, 46, 49, 63, 162, 222 💬
38Prednisone acetate tablets
(D00473)
[2] Prednisone,
Prednisone acetate
[2] Prednisone (D00473),
Prednisone acetate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 40, 224 💬
39Prednisone alone
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 11, 66 💬
40Prednisone and belimumab
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 300 💬
41Prednisone and cyclophosphamide
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
42Prednisone and mycophenolate mofetil
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 300 💬
43Prednisone and ustekinumab treatment
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
44Prednisone arrow 20MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
45Prednisone arrow 5 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
46Prednisone capsule
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
47Prednisone capsules
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
48Prednisone discontinuation
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
49Prednisone DOC generici
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 90 💬
50Prednisone DOC generici - 5 MG compresse 10 compresse IN blister PVC-pvdc/ALU
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 19 💬
51Prednisone DOC generici - 5 MG compresse 30 compresse IN blister PVC-pvdc/ALU
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 300 💬
52Prednisone IN full dose
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
53Prednisone or prednisolone
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 84 💬
54Prednisone oral product
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
55Prednisone plus cyclophosphamide
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
56Prednisone plus exercise
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
57Prednisone tablet
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
58Prednisone tablets USP, 1 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 41, 46 💬
59Prednisone tablets USP, 10 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
60Prednisone tablets USP, 1MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
61Prednisone tablets USP, 2.5 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
62Prednisone tablets USP, 2.5MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
63Prednisone tablets USP, 20MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
64Prednisone tablets USP, 5 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 41, 46 💬
65Prednisone tablets USP, 5MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
66Prednisone tablets, USP
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 41, 43, 44 💬
67Prednisone tablets, USP 10 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
68Prednisone tablets, USP 2.5 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
69Prednisone tablets, USP 5 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
70Prednisone tablets, USP, 1 MG
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
71Prednisone therapy and pharmacokinetic
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
72Prednisone treatment
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
73Prednisone, ciclosporin and mycophenolate mofetil
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
74Prednisone, cyclophosphamide
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 40 💬
75Prednisone, FK506, MMF
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
76Prednisone, LOW dose rituximab
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 61 💬
77Prednisone, methylprednisolone,cyclophosphamides
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45 💬
78Prednisone,methylprednisone and cyclophosphamide
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
79Prednisone/methylprenisolone
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 96 💬
80Prednisone/prednisolone
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 35 💬
81Pyridostigmine, prednisone, tacrolimus
(D00473)
[1] Pyridostigmine[1] Pyridostigmine bromide 💬 [1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 11 💬
82Rituxan, cyclophosphamide, vincristine, prednisone
(D00473)
[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 63 💬
83Tacrolimus combined with prednisone
(D00473)
[1] Tacrolimus[2] Tacrolimus ,
Tacrolimus 💬
[5] PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 222 💬
84Thalidomide, cyclophosphamide and prednisone
(D00473)
[1] Thalidomide[1] Thalidomide 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 331 💬
85Thymectomy plus prednisone
(D00473)
[1] Prednisone[1] Prednisone (D00473) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 11 💬
86Vinblastine, vincristine, prednisone, daunorubicin
(D00473)
[1] Vinblastine[2] Vinblastine sulfate ,
Vinblastine 💬
[9] TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬
[11] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬[1] 65 💬